PREVALENCE OF TRANSFUSION-TRANSMISSION INFECTIONS AMONG DONORS OF THE SUMY DEPARTMENT OF PROCUREMENT OF BLOOD AND ITS COMPONENTS LLC “CBS “BIOPHARMA PLASMA”

Abstract

The article updates the problem of infectious safety of donor blood and its components in Ukraine. The article highlights the results of a study of the prevalence of markers of transfusion-transmissible infections in the blood of donors of the Sumy department of blood procurement and its components LLC «CBS «BIOPHARMA PLAZMA» in 2019–2023. The study was carried out within the framework of Agreement No. 562 dated 03/22/2016 on scientific, methodological and educational cooperation between Sumy Regional Blood Service LLC and Sumy State Pedagogical University named after A.S. Makarenko on the basis of Biopharma Plasma of Sumy. The study of the prevalence of markers of the causative agents of HIV infection, hepatitis B and C was carried out on the basis of data from the institution’s annual reports and its own research. Statistical indicators are calculated in the form of relative values in percentages and per 100,000 donations. It was established that among the primary donors of the Sumy department of blood collection and its components LLC «CBS «BIOPHARMA PLAZMA» during 2019–2023, the relative number of carriers of HIV, hepatitis B and C viruses among primary donors was 0.02%, 0.04% and 0 .26% respectively, among repeat and regular donors, the relative number of such persons was 1.4, 2.1, and 8.6 times, respectively. It was shown that the level of prevalence of markers of transfusiontransmissible infections among donors per 100,000 donations was on average about 37 for HIV infection, about 57 for hepatitis B, and about 265 for hepatitis C. The level of prevalence of markers of HIV infection among primary and repeated and regular donors during 2019–2023 tended to decrease, markers of hepatitis C – to increase, markers of hepatitis B among primary donors – to increase, among repeated and regular donors – to decrease. The specific weight of repeated positive results among primary positive for hepatitis B and C markers was on average about 90 and 40% among primary donors, respectively, among repeated and regular donors – about 80 and 53%.